Daily aspirin may cut ovarian cancer risk
Aspirin is well-known for protecting the heart, and according to a new study, you may be able to add “reduces the risk of ovarian cancer” to the list of health benefits, too.
National Cancer Institute researchers, publishing in the Journal of the National Cancer Institute, analyzed 12 studies of almost 8,000 women with ovarian cancer and nearly 12,000 without the disease, concentrating on how using pain relievers such as aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen impacted ovarian cancer risk. The scientists discovered that taking an aspirin daily appeared to lower the incidence of ovarian cancer by 20 percent when compared with those women who used aspirin less than once a week. No statistically significant difference was seen between women who used nonaspirin NSAIDs at least once a week and those who used them less often, nor did there seem to be a connection between using acetaminophen and the likelihood of developing ovarian cancer. However, researchers note, the findings do not prove cause and effect, and additional research is needed because regular aspirin use can trigger complications such as gastrointestinal bleeding and stroke.